The total return over the past 12 months is -48.39% vs. +16.94% for the S&P 500. So far it's up -65.34% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (48.39%) | (31.45%) | (53.23%) | N/A | N/A | N/A |
| Total Return CAGR | (48.39%) | (31.45%) | (53.23%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Passage Bio, Inc. (PASG)
| Year | Start price | End price | PASG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.80 | $4.09 | (65.34%) | +14.51% | (79.85%) |
| 2025 | $11.34 | $11.80 | +4.06% | +17.72% | (13.66%) |
| 2024 | $20.20 | $11.34 | (43.86%) | +24.89% | (68.75%) |
| 2023 | $27.60 | $20.20 | (26.81%) | +26.19% | (53.00%) |
| 2022 | $127.00 | $27.60 | (78.27%) | (18.17%) | (60.10%) |
| 2021 | $511.40 | $127.00 | (75.17%) | +28.74% | (103.91%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
